Mild pain relief for GSK

Financial Times
Financial Times
  • 5 years ago
GlaxoSmithKline has become embroiled in a corruption probe concerning some of its Chinese staff, but its first-half numbers helped to soothe market nerves. Lex's Julia Grindell and Oliver Ralph discuss the UK drugmaker's results and the importance of China to the business. For more video content from the Financial Times, visit http://www.FT.com/video

Recommended

2:54
I
Up next
Financial Times Business of Football conference 2013
Financial Times
4:44
More Women Makes Business Sense - Financial Times Report
Financial Times
7:02
John Fallon discusses sale of Financial Times | FT Business
Financial Times
3:18
GSK China case raises foreign fears | FT Business
Financial Times
4:55
Aston Martin Gets Ready To Rumble - The Financial Times
Financial Times
2:20
The Financial Times 'FT.com' Site Tour
Financial Times
0:20
Financial Times Fingertips Advert - International Version
Financial Times
10:20
China's 'Shock and Awe' & the Arms War Threat - Financial Times Analysis
Financial Times
1:29
Find your next adventure at the Financial Times: My city, La Paz
Financial Times
9:37
White House Responds To Weak Job Numbers - Financial Times
Financial Times
4:24
The Revival Of Rio De Janeiro - Financial Times
Financial Times
3:34
Penjelasan proses pemilu di Indonesia oleh Financial Times
Financial Times
1:15
Haiti One Year after the Quake - Financial Times
Financial Times
4:27
Silicon Roundabout - Hype or Reality? - Financial Times Report
Financial Times
1:51
What makes The 125 different? I Financial Times
Financial Times
4:06
Android Phones vie for Attention - Financial Times
Financial Times
3:27
Nokia's Dramatic Profit Warning - Financial Times Analysis
Financial Times
3:57
UK Government Faces Tough 2011 - Financial Times Analysis
Financial Times
3:56
Aerobatics In A Pitts Special Biplane - The Financial Times
Financial Times
2:22
Find your next adventure at the Financial Times
Financial Times
3:01
France announces record $16bn in foreign investment
CGTN Europe
3:01
GSK investit 250 millions dans une unité de lyophilisation à Wavre
Lavenir.net
1:51
Nouvel investissement majeur chez GSK à Wavre : un nouveau centre pour produire des vaccins lyophilisés
Lavenir.net
3:23
Un nouveau centre pour produire des vaccins lyophilisés par GSK ouvre à Wavre
Sudinfo.be
4:05
Battle of the pharmaceutical giants: GSK sues Pfizer over claims Covid jab
1 Breaking News US
3:10
Leadership Next: GSK CEO, Emma Walmsley
Fortune

Financial Times

2:31
EU leaders offer the UK a six-month Brexit delay
Financial Times
1:11
ECB keeps monetary policy unchanged
Financial Times
1:59
Theresa May granted Brexit delay until end of October
Financial Times
12:28
Crunched: philanthropy versus tax avoidance
Financial Times
1:39
How scientists took first picture of a black hole
Financial Times
0:56
Theresa May arrives in Brussels seeking Brexit delay
Financial Times

Featured channels

More from
Met Office
More from
ODN
More from
SWNS
More from
GoodtoKnow
More from
Evening Standard
More from
FourFourTwo